2. UroToday Home
  3. Video Lectures

Bladder Cancer Videos

Advances from 2020 in the Management of Muscle Invasive Non-Metastatic Bladder Cancer - Bernard Bochner
January 26, 2021
Details
EAU Guidelines on Non-Muscle-Invasive Bladder Cancer 2020 Update - Marek Babjuk
December 3, 2020
Details
DNA Based Markers in High-risk Non-Muscle Invasive BCG Unresponsive Bladder Cancer - Alexander Wyatt
November 15, 2020
Details
Pembrolizumab in High-Risk, BCG Unresponsive Non-Muscle Invasive Bladder Cancer - Arjun Balar
October 24, 2020
Details
A Patient Perspective on High-Risk Non-Muscle Invasive BCG Unresponsive Bladder Cancer- Karen Sachse
October 22, 2020
Details
How to Define Treatment Failure After BCG Treatment for Nonmuscle-Invasive Bladder Cancer - Peter Black
October 14, 2020
Details
High-Risk Non Muscle-Invasive BCG Unresponsive Bladder Cancer - Molecular Subtypes - Woonyoung Choi
October 14, 2020
Details
Vicineum for High-Risk Non-Muscle-Invasive BCG Unresponsive Bladder Cancer - Rian J. Dickstein
November 15, 2020
Details
The Role of the PD-L1 Checkpoint in BCG Resistance - Max Kates
November 15, 2020
Details
Variant Histology Urothelial Carcinoma: A Patient Case - Makarand Khochikar
August 26, 2020
Details
T2 N0 M0 High-grade Urothelial Carcinoma Patient Case Study with Cushingoid Features Undergoing Radical Cystectomy in Neobladder - Makarand Khochikar
August 25, 2020
Details
Clinically Node Positive Bladder Cancer and The Timing of Surgery - Neema Navai
August 18, 2020
Details
The Management of Bladder Cancer During Pregnancy - Makarand Khochikar
August 16, 2020
Details
Adherence to Guidelines-Based Management of Non-Muscle Invasive Bladder Cancer Among Society of Urologic Oncology (SUO) Members - Justin T. Matulay
August 4, 2020
Details
Urinary Diversion in Women Following Radical Cystectomy - Renu Eapen
August 4, 2020
Details
Radical Cystectomy and The Importance of Oncological Concepts in Surgical Approach - Rafael Sanchez Salas
August 16, 2020
Details
T2 N0 M0 Muscle-invasive Bladder Cancer Patient Case - Makarand Khochikar
August 15, 2020
Details
Results of the SUO CTC Phase III Nadofaragene Firadenovec Trial for BCG Unresponsive NMIBC - Colin Dinney
July 6, 2020
Details
Blue Light Cystoscopy with Cysview®: Tips and Tricks - Anne Schuckman
June 30, 2020
Details
The RESECT Study: Improving Quality in TURBT Surgery - Veeru Kasivisvanathan
June 30, 2020
Details
AUA Guidelines Case-Based Panel Discussion: Bladder Cancer (Non-muscle and Muscle Invasive) - Joshua Meeks and Sima Porten
June 26, 2020
Details
Macro and Microeconomics of Blue Light Cystoscopy with CYSVIEW® in Non-Muscle Invasive Bladder Cancer - Stephen Williams
June 24, 2020
Details
A Discussion on Implementing the Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer AUA/ASCO/ASTRO/SUO Guidelines - Sam Chang
June 14, 2020
Details
Improving and Optimizing Transurethral Resection of Bladder Tumor (TURBT) Outcomes - Hugh Mostafid
June 10, 2020
Details
Treatment Options for Bacillus Calmette-Guérin (BCG) Refractory Bladder Cancer Disease - Wassim Kassouf
June 7, 2020
Details
Role of Blue Light Cystoscopy in Bladder Cancer Management - Trinity Bivalacqua
May 31, 2020
Details
Bladder Preservation Protocols for Muscle-Invasive Urothelial Carcinoma - Arjun Balar
May 26, 2020
Details
Weathering the Current BCG Shortage Crisis - Michael O’Donnell
May 26, 2020
Details
Blue Light Cystoscopy with Cysview for Management of Non Muscle Invasive Bladder Cancer - Joshua Meeks
May 15, 2020
Details
Implications of the Bacillus Calmette-Guérin (BCG) Shortage - Joshua Meeks
May 12, 2020
Details
Improving Research and Clinical Care, Bladder Cancer in Women - Jean Hoffman-Censits
May 10, 2020
Details
Current and Emerging Therapies for Non-Muscle Invasive Bladder Cancer after BCG - Chris Wallis & Zach Klaassen
April 14, 2020
Details
Phase III Nadofaragene Firadenovec for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Joshua J. Meeks
February 28, 2020
Details
The BCG Shortage - What To Do In This Setting - Joshua Meeks
January 16, 2020
Details
Advancements in BCG Unresponsive Bladder Cancer: Highlights from the 2019 SUO Meeting - Joshua Meeks
January 16, 2020
Details
A New Era In Systemic Therapies, Pembrolizumab for High Risk Non-Muscle Invasive BCG-Refractory Patients - Arjun Balar
January 8, 2020
Details
Utilizing Change Management for Successful Implementation of Blue light cystoscopy (BLC™) - Rebecca Roe
December 4, 2019
Details
Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy - Badrinath Konety
November 21, 2019
Details
Guided Imagery for Urologic Surgery - Sima Porten
October 31, 2019
Details
Consensus Statement on Flexible Blue Light Cystoscopy (BLC™) with Cysview® - Yair Lotan
October 17, 2019
Details
Journal Club: The Evaluation of Cxbladder and Adjudication of Atypical Cytology - Sia Daneshmand
October 15, 2019
Details
Comparative Analyses of Costs and Survival Between Radical Cystectomy and Trimodal Therapy - Stephen Williams
September 11, 2019
Details
Blue Light Cystoscopy with CYSVIEW: Improving Detection Rates of Bladder Cancer in the Clinic - Yair Lotan
August 12, 2019
Details
Blue Light Cystoscopy (BLC™): What Urologist Want to Know - Anne Schuckman
August 5, 2019
Details
Toxicity Management with Checkpoint Inhibitor Therapy - Thomas Powles
July 1, 2019
Details
Bladder Cancer in Women - Morgan Roupret
June 17, 2019
Details
BCG Shortage An Update - Jonathan Rubenstein
May 4, 2019
Details
The Role of the Surgeon in the Treatment of Bladder Cancer - Jens Bedke
June 13, 2019
Details
Immunotherapy in the Peri-Operative Setting for Bladder Cancer - Thomas Powles
June 14, 2019
Details
What is New on Bladder Cancer Treatment: ASCO GU 2019? - Josh Meeks
April 18, 2019
Details
ERAS in Bladder Cancer - Sia Daneshmand
April 15, 2019
Details
The State of Immunotherapy in Bladder Cancer - Thomas Powles
April 15, 2019
Details
Bladder Cancer in Women: Improving Diagnosis and Treatment - Jean Hoffman-Censits
April 15, 2019
Details
Optimal Surgical Approaches in Cystectomy - Piyush Agarwal
July 22, 2019
Details
Improving Outcomes in Bladder Cancer - Arnulf Stenzl
June 23, 2019
Details
The Role of the Surgeon in the Management of Metastatic Bladder Cancer - Brant Inman
April 3, 2019
Details
Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer - Stephen B Williams
June 27, 2019
Details
Defining BCG-Unresponsive and The Pathway to Clinical Trials in Treating NMIBC - Ashish Kamat
June 5, 2019
Details
BCG Shortage 2019: Managing Through Treatment and Reimbursement Issues - Neal Shore, Ashish Kamat, and Jonathan Rubenstein
March 4, 2019
Details
2019 BCG Shortage-Perspectives from Josh Meeks
March 1, 2019
Details
Blue Light Cystoscopy with Cysview® in the Surveillance of Bladder Cancer - Sia Daneshmand
February 28, 2019
Details
The Importance of TURBT and the Benefits of Enhanced Cystoscopy - Sima P. Porten
February 1, 2019
Details
Efficacy and Safety of Flexible BLC with Cysview® in the Surveillance of Bladder Cancer - Sia Daneshmand
February 1, 2019
Details
Patient Reported Outcomes in the Use of Blue Light Cystoscopy in the Surveillance of Bladder Cancer - Angela B. Smith
January 25, 2019
Details
Blue Light Cystoscopy for Diagnosis of Bladder Cancer - A Journal Club Review by Badrinath Konety
January 7, 2019
Details
Evolution of Technology and Technique in Bladder Cancer - Ashish Kamat
December 10, 2018
Details
Immuno-Oncology in Bladder Cancer: The Urologist's Role - Noah Hahn
November 15, 2018
Details
Is There an Optimal TURBT Technique and the Color War? - Ashish Kamat
November 15, 2018
Details
Keynote-057 Trial for High-Risk Non-Muscle Invasive Bladder Cancer - Evan Yu
November 9, 2018
Details
Is There Still a Role for Chemotherapy in Bladder and Prostate Cancer - Maria De Santis
November 7, 2018
Details
Immunotherapy in Bladder Cancer - Arjun Balar
November 7, 2018
Details
High Grade Non-Muscle Invasive Bladder Cancer and BCG Refractory Patient - Josh Meeks
September 21, 2018
Details
Update on Bladder Cancer, Current Trials and Treatments - Bishoy Faltas
June 24, 2018
Details
CARMENA in mRCC and Surgical Management Cases in Bladder Cancer from ASCO 2018 - Tom Keane
June 23, 2018
Details
Updates in Advanced Urothelial Carcinoma - Highlights from ASCO 2018 - Petros Grivas
June 21, 2018
Details
FDA ALERT: Efficacy Issue Identified in Some Patients Taking Pembrolizumab or Atezolizumab as Monotherapy to Treat Advanced Urothelial Cancer - Petros Grivas
June 21, 2018
Details
Update in Immuno-Oncology in Bladder Cancer - Arjun Balar
June 15, 2018
Details
Journey from Oncologist to Cancer Survivor and Patient Advocate - Burton Needles
May 22, 2018
Details
Setting the Stage for the BCG Unresponsive Population - Interview with Ashish Kamat
May 19, 2018
Details
Helping Patients Cope after Major Interventions for Bladder Cancer Therapy
May 17, 2018
Details
The Changing Landscape in Advanced Bladder Cancer - Tom Keane
April 19, 2018
Details
Advances in Bladder Cancer - Systemic Therapies Including Immunotherapy - Petros Grivas
April 8, 2018
Details
Minimizing Treatment Burden and Biomarkers in Bladder Cancer - Badrinath Konety
April 18, 2018
Details
A Revolutionizing Time in Immuno-Oncology for Bladder Cancer - Neal Shore
March 14, 2018
Details
Enhanced Recovery After Surgery (ERAS) for Radical Cystectomy: History, Rationale and Programmatic Implementation - Thomas Guzzo
February 19, 2018
Details
Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde
January 12, 2018
Details
Enhanced Recovery After Surgery (ERAS) Radical Cystectomy and Urinary Diversion- Ashish Kamat
January 25, 2017
Details